Genzyme Corporation v. Novartis Gene Therapies, Inc.
Summary
Genzyme sues Novartis for allegedly infringing patents related to gene therapy treatments.
Summary generated by AI from public docket data. Verify against the original filing before relying on it.
Counsel of record
For the plaintiff
- Independent counselAmanda K. Antons, Brian M. Goldberg, Daniel R. Roberts +8 more
- Wilks Law, LLCDavid E. Wilks, Donald C. Vavala , III, Scott B. Czerwonka
For the defendant
- Independent counselCora R. Holt, Jeffrey D. Smyth, John D. Livingstone +1 more
- McCarter & English, LLPAlexandra M. Joyce, Daniel M. Silver
- Court
- DED
- Docket no.
- 1:23-cv-00554
- Nature of suit
- Patent
- Filed
- 2023-05-19
- Last filing
- 2024-02-14
Cause
35:1 Patent Infringement
Entities in this case
Parties
Novartis Pharmaceuticals Corporation Novartis Gene Therapies, Inc. Aventis Inc. Genzyme Corporation